PARKHOSPS
PARKHOSPS · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for PARKHOSPS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Certificate under SEBI (Depositories and Participants) Regulations, 2018
03 Jul 2026
Analysts/Institutional Investor Meet/Con. Call Updates
03 Jul 2026
Capacity addition
30 Jun 2026
Trading Window
26 Jun 2026
Reply to Clarification- Financial results
13 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
08 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
08 Jun 2026
Diversification/Disinvestment
05 Jun 2026
Disclosure under SEBI Takeover Regulations
25 May 2026
Acquisition
25 May 2026
Outcome of Board Meeting
25 May 2026
Clarification - Financial Results
22 May 2026
Acquisition
20 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates
18 May 2026
Monitoring Agency Report
16 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
12 May 2026
PARK MEDI WORLD LIMITED has informed the Exchange about Board Meeting to be held on 12-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
12 May 2026
To consider and approve the standalone and consolidated audited financial results of the Company for the quarter and year ended on March 31, 2026.
28 Jan 2026
PARK MEDI WORLD LIMITED has informed the Exchange about Board Meeting to be held on 28-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
28 Jan 2026
To consider and approve the financial results for the period ended December 31, 2025